Tempus AI (TEM) stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 66 to 78.
When To Sell Stocks To Lock In Profits And Minimize Losses
This unique rating identifies market leadership by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research shows that the best stocks typically have an RS Rating of at least 80 as they begin their biggest runs. See if Tempus AI stock can continue to rebound and hit that benchmark.
Tempus AI working stock is working on a cup without handle with a 74.83 entry. See if it can clear the breakout price in volume at least 40% above average.
The healthcare technology firm posted 0% earnings growth in its most recent report, while sales growth came in at 90%.
Tempus AI stock holds the No. 5 rank among its peers in the Medical-Research Equipment/Services industry group. Medpace Holdings (MEDP) is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
YOU MAY ALSO LIKE:
Learn How To Time The Market With IBD's ETF Market Strategy
Find Today's Best Growth Stocks To Watch With IBD 50
Find The Best Long-Term Investments With IBD Long-Term Leaders
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。